Papapetropoulos Spyros

CIK 00018326944 companiesBURLINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001832694

Recent Transactions

22 trades

Award
Neuphoria Therapeutics Inc.$NEUP
Employee Stock Option (Right-to- Buy)
2025-08-27$8.27/sh+34,559→ 74,088 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2025-06-04$3.20/sh+1,764→ 7,174 total
Award
Neuphoria Therapeutics Inc.$NEUP
Employee Stock Option (Right-to-Buy)
2025-04-16$5.16/sh+27,000→ 39,529 total
Award
Neuphoria Therapeutics Inc.$NEUP
Employee Stock Option (Right-to-Buy)
2025-04-16$5.16/sh+270,000→ 282,529 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2024-06-05$7.05/sh+1,764→ 5,410 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2023-05-10$0.27/sh+30,000→ 62,000 total
Purchase
Lipocine Inc.$LPCN
Common stock
2022-11-22$0.47/sh+21,739→ 21,739 total
Exercise/Conversion
Vigil Neuroscience, Inc.
Common Stock
2022-11-18$1.89/sh+300→ 4,300 total
Sale
Vigil Neuroscience, Inc.
Common Stock
2022-11-18$14.00/sh−300→ 4,000 total
Exercise/Conversion
Vigil Neuroscience, Inc.
Stock Option Grant (Right to Buy)
2022-11-18−300→ 149,604 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2022-06-08$0.92/sh+22,000→ 32,000 total
Purchase
Vigil Neuroscience, Inc.
Common Stock
2022-05-03$3.40/sh+4,000→ 4,000 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2022-04-11$1.16/sh+10,000→ 10,000 total
Award
Vigil Neuroscience, Inc.
Stock Option Grant (Right to Buy)
2022-03-01+75,500→ 75,500 total
Disposition from Tender
Adamas Pharmaceuticals Inc
Common Stock
2021-11-24−20,975→ 0 total
Disposition to Issuer
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2021-11-24−20,000→ 0 total
Disposition to Issuer
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2021-11-24−10,000→ 0 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2021-06-02+10,000→ 10,000 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2021-06-02+5,000→ 20,975 total
Purchase
Adamas Pharmaceuticals Inc
Common Stock
2021-03-11$5.06/sh+5,975→ 15,975 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2020-11-22+10,000→ 10,000 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Rightto Buy)
2020-11-22+20,000→ 20,000 total

Papapetropoulos Spyros

Recent Transactions

Companies

Recent Filings

Address